Ludwig, H., Greil, R., Masszi, T., Spicka, I., Shpilberg, O., Hajek, R., . . . Viterbo, L. (2015). Bortezomib, thalidomide and dexamethasone, with or without cyclophosphamide, for patients with previously untreated multiple myeloma: 5‐year follow‐up. John Wiley and Sons Inc.
Chicago Style CitationLudwig, Heinz, et al. Bortezomib, Thalidomide and Dexamethasone, With or Without Cyclophosphamide, for Patients With Previously Untreated Multiple Myeloma: 5‐year Follow‐up. John Wiley and Sons Inc, 2015.
MLA CitationLudwig, Heinz, et al. Bortezomib, Thalidomide and Dexamethasone, With or Without Cyclophosphamide, for Patients With Previously Untreated Multiple Myeloma: 5‐year Follow‐up. John Wiley and Sons Inc, 2015.
Warning: These citations may not always be 100% accurate.